• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿舞蹈症动物模型中对3-硝基丙酸的易感性增加。

Increased vulnerability to 3-nitropropionic acid in an animal model of Huntington's disease.

作者信息

Bogdanov M B, Ferrante R J, Kuemmerle S, Klivenyi P, Beal M F

机构信息

Neurochemistry Laboratory, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA.

出版信息

J Neurochem. 1998 Dec;71(6):2642-4. doi: 10.1046/j.1471-4159.1998.71062642.x.

DOI:10.1046/j.1471-4159.1998.71062642.x
PMID:9832167
Abstract

There is substantial evidence for both metabolic dysfunction and oxidative damage in Huntington's disease (HD). In the present study, we used in vivo microdialysis to measure the conversion of 4-hydroxybenzoic acid to 3,4-dihydroxybenzoic acid (3,4-DHBA) as a measure of hydroxyl radical production in a transgenic mouse model of HD, as well as in littermate controls. The conversion of 4-hydroxybenzoic acid to 3,4-DHBA was unchanged in the striatum of transgenic HD mice at baseline. Following administration of the mitochondrial toxin 3-nitropropionic acid (3-NP), there were significant increases in 3,4-DHBA generation in both control and transgenic HD mice, and the increases in the transgenic HD mice were significantly greater than those in controls. Furthermore, administration of 3-NP produced significantly larger striatal lesions in transgenic HD mice than in littermate controls. The present results show increased sensitivity to the mitochondrial toxin 3-NP in transgenic HD mice, which suggests metabolic dysfunction in this mouse model of HD.

摘要

有大量证据表明亨廷顿舞蹈症(HD)存在代谢功能障碍和氧化损伤。在本研究中,我们利用体内微透析技术,在HD转基因小鼠模型及其同窝对照小鼠中,测量4-羟基苯甲酸向3,4-二羟基苯甲酸(3,4-DHBA)的转化,以此作为羟自由基产生的指标。在基线时,转基因HD小鼠纹状体中4-羟基苯甲酸向3,4-DHBA的转化未发生变化。给予线粒体毒素3-硝基丙酸(3-NP)后,对照小鼠和转基因HD小鼠的3,4-DHBA生成均显著增加,且转基因HD小鼠的增加幅度显著大于对照小鼠。此外,给予3-NP后,转基因HD小鼠纹状体中的损伤明显大于同窝对照小鼠。目前的结果表明,转基因HD小鼠对线粒体毒素3-NP的敏感性增加,这表明该HD小鼠模型存在代谢功能障碍。

相似文献

1
Increased vulnerability to 3-nitropropionic acid in an animal model of Huntington's disease.亨廷顿舞蹈症动物模型中对3-硝基丙酸的易感性增加。
J Neurochem. 1998 Dec;71(6):2642-4. doi: 10.1046/j.1471-4159.1998.71062642.x.
2
Elevated "hydroxyl radical" generation in vivo in an animal model of amyotrophic lateral sclerosis.在肌萎缩侧索硬化症动物模型中,体内“羟基自由基”生成增加。
J Neurochem. 1998 Sep;71(3):1321-4. doi: 10.1046/j.1471-4159.1998.71031321.x.
3
Mice transgenic for the Huntington's disease mutation are resistant to chronic 3-nitropropionic acid-induced striatal toxicity.携带亨廷顿舞蹈病突变的转基因小鼠对慢性3-硝基丙酸诱导的纹状体毒性具有抗性。
J Neurochem. 2000 Nov;75(5):2163-71. doi: 10.1046/j.1471-4159.2000.0752163.x.
4
3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc superoxide dismutase transgenic mice.
J Neurochem. 1995 Aug;65(2):919-22. doi: 10.1046/j.1471-4159.1995.65020919.x.
5
Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.长期用3-硝基丙酸治疗的大鼠出现可量化的运动迟缓、步态异常及亨廷顿舞蹈病样纹状体损伤。
Neuroscience. 1997 Jul;79(1):45-56. doi: 10.1016/s0306-4522(96)00602-1.
6
Mice deficient in L-12/15 lipoxygenase show increased vulnerability to 3-nitropropionic acid neurotoxicity.缺乏L-12/15脂氧合酶的小鼠对3-硝基丙酸神经毒性的易感性增加。
Neurosci Lett. 2017 Mar 16;643:65-69. doi: 10.1016/j.neulet.2017.02.031. Epub 2017 Feb 14.
7
A novel therapeutic application of solid lipid nanoparticles encapsulated thymoquinone (TQ-SLNs) on 3-nitroproponic acid induced Huntington's disease-like symptoms in wistar rats.固体脂质纳米粒包裹的百里醌(TQ-SLNs)对3-硝基丙酸诱导的Wistar大鼠亨廷顿病样症状的新型治疗应用
Chem Biol Interact. 2016 Aug 25;256:25-36. doi: 10.1016/j.cbi.2016.05.020. Epub 2016 May 17.
8
CREB is a key regulator of striatal vulnerability in chemical and genetic models of Huntington's disease.CREB 是亨廷顿病化学和遗传模型中纹状体易损性的关键调节因子。
Neurobiol Dis. 2009 Nov;36(2):259-68. doi: 10.1016/j.nbd.2009.07.014. Epub 2009 Jul 24.
9
Mitochondrial toxin 3-nitropropionic acid produces startle reflex abnormalities and striatal damage in rats that model some features of Huntington's disease.线粒体毒素3-硝基丙酸会在模拟亨廷顿舞蹈症某些特征的大鼠中引发惊吓反射异常和纹状体损伤。
Neurosci Lett. 1997 Aug 8;231(2):103-7. doi: 10.1016/s0304-3940(97)00482-5.
10
Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats.纹状体多巴胺水平在3-硝基丙酸诱导的大鼠亨廷顿病中,促使纹状体中羟自由基的生成及随后的神经退行性变。
Neurochem Int. 2009 Nov;55(6):431-7. doi: 10.1016/j.neuint.2009.04.013. Epub 2009 May 4.

引用本文的文献

1
Protective Effects of Antcin H Isolated from Antrodia cinnamomea Against Neuroinflammation in Huntington's Disease via NLRP3 Inflammasome Inhibition.从樟芝中分离出的安替辛H通过抑制NLRP3炎性小体对亨廷顿舞蹈病神经炎症的保护作用
J Neuroimmune Pharmacol. 2024 Dec 2;20(1):1. doi: 10.1007/s11481-024-10161-7.
2
Oxidative Stress in DNA Repeat Expansion Disorders: A Focus on NRF2 Signaling Involvement.DNA 重复扩展障碍中的氧化应激:聚焦 NRF2 信号通路的参与。
Biomolecules. 2020 May 1;10(5):702. doi: 10.3390/biom10050702.
3
Reactive oxygen species induce neurite degeneration before induction of cell death.
活性氧在诱导细胞死亡之前会引发神经突退化。
J Clin Biochem Nutr. 2016 Nov;59(3):155-159. doi: 10.3164/jcbn.16-34. Epub 2016 Aug 6.
4
3-Nitropropionic acid induces ovarian oxidative stress and impairs follicle in mouse.3-硝基丙酸诱导小鼠卵巢氧化应激并损害卵泡。
PLoS One. 2014 Feb 5;9(2):e86589. doi: 10.1371/journal.pone.0086589. eCollection 2014.
5
Curcumin nanoparticles attenuate neurochemical and neurobehavioral deficits in experimental model of Huntington's disease.姜黄素纳米颗粒减轻亨廷顿舞蹈病实验模型中的神经化学和神经行为缺陷。
Neuromolecular Med. 2014 Mar;16(1):106-18. doi: 10.1007/s12017-013-8261-y. Epub 2013 Sep 6.
6
Multi-tasking: nuclear transcription factors with novel roles in the mitochondria.多任务处理:在线粒体中具有新功能的核转录因子。
Trends Cell Biol. 2012 Aug;22(8):429-37. doi: 10.1016/j.tcb.2012.05.001. Epub 2012 Jun 14.
7
Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.亨廷顿病的病理生理学:突触和受体功能的时变改变。
Neuroscience. 2011 Dec 15;198:252-73. doi: 10.1016/j.neuroscience.2011.08.052. Epub 2011 Aug 27.
8
Mitochondrial matters of the brain: the role in Huntington's disease.脑线粒体问题:在亨廷顿病中的作用。
J Bioenerg Biomembr. 2010 Jun;42(3):193-8. doi: 10.1007/s10863-010-9290-y.
9
The failure of mitochondria leads to neurodegeneration: Do mitochondria need a jump start?线粒体功能障碍导致神经退行性变:线粒体需要启动吗?
Adv Drug Deliv Rev. 2009 Nov 30;61(14):1316-23. doi: 10.1016/j.addr.2009.07.016. Epub 2009 Aug 27.
10
Mouse models of Huntington's disease and methodological considerations for therapeutic trials.亨廷顿舞蹈症的小鼠模型及治疗试验的方法学考量
Biochim Biophys Acta. 2009 Jun;1792(6):506-20. doi: 10.1016/j.bbadis.2009.04.001. Epub 2009 Apr 10.